Cuba reported over 29 thousand new COVID-19 cases and 258 deaths up to May 25th over a daily infection average of more than 1 thousand and 10 deaths, which are the highest figures since the pandemic’s onset here in March 2020.

Image: Santiago Romero Chang. Cuba’s Mambisa among the world’s five nasal anti-Covid-19 vaccine candidates. Developed by the Cuban Center for Genetic Engineering and Biotechnology (CIGB)

Cuba approves its two first High-Tech companies: The Center for Genetic Engineering and Biotechnology (CIGB) and the Biotechnology and Pharmaceutical Industry Enterprise (BIOCEN)